Mollie E Barnard, Bo Qin, Marc A Emerson, Etienne X Holder, Matthew R Dunn, Shromona Sarkar, Nuo N Xu, Yutong Li, Christine B Ambrosone, Elisa V Bandera, Julie R Palmer, Melissa A Troester, Terry Hyslop
{"title":"美国黑人妇女中健康的社会驱动因素与乳腺癌诊断阶段之间的关系。","authors":"Mollie E Barnard, Bo Qin, Marc A Emerson, Etienne X Holder, Matthew R Dunn, Shromona Sarkar, Nuo N Xu, Yutong Li, Christine B Ambrosone, Elisa V Bandera, Julie R Palmer, Melissa A Troester, Terry Hyslop","doi":"10.1038/s41523-025-00804-0","DOIUrl":null,"url":null,"abstract":"<p><p>U.S. Black women have disproportionately high breast cancer mortality, partly due to later-stage diagnoses. We examined how social drivers of health (SDOH) relate to stage at diagnosis by analyzing data from 4,995 breast cancer survivors in the Black Women's Health Study, Carolina Breast Cancer Study, and Women's Circle of Health Studies. SDOH were self-reported and stage was ascertained from medical records. We used polytomous logistic regression to estimate odds ratios (ORs) for diagnosis at stages III/IV or II versus stage I (referent), adjusting for age, insurance status, and income. Meta-analyzed results indicated that underutilization of screening mammography (OR = 3.21, 95% CI 1.90-5.43) and income below the federal poverty line (OR = 1.91, 95% CI 1.17-3.10) were significantly associated with later stage diagnosis (III/IV). ORs for lack of insurance and lower education were above 1.0, but not consistently statistically significant. These findings substantiate the importance of the affordability and utilization of breast cancer screening.</p>","PeriodicalId":19247,"journal":{"name":"NPJ Breast Cancer","volume":"11 1","pages":"85"},"PeriodicalIF":7.6000,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12328792/pdf/","citationCount":"0","resultStr":"{\"title\":\"Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women.\",\"authors\":\"Mollie E Barnard, Bo Qin, Marc A Emerson, Etienne X Holder, Matthew R Dunn, Shromona Sarkar, Nuo N Xu, Yutong Li, Christine B Ambrosone, Elisa V Bandera, Julie R Palmer, Melissa A Troester, Terry Hyslop\",\"doi\":\"10.1038/s41523-025-00804-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>U.S. Black women have disproportionately high breast cancer mortality, partly due to later-stage diagnoses. We examined how social drivers of health (SDOH) relate to stage at diagnosis by analyzing data from 4,995 breast cancer survivors in the Black Women's Health Study, Carolina Breast Cancer Study, and Women's Circle of Health Studies. SDOH were self-reported and stage was ascertained from medical records. We used polytomous logistic regression to estimate odds ratios (ORs) for diagnosis at stages III/IV or II versus stage I (referent), adjusting for age, insurance status, and income. Meta-analyzed results indicated that underutilization of screening mammography (OR = 3.21, 95% CI 1.90-5.43) and income below the federal poverty line (OR = 1.91, 95% CI 1.17-3.10) were significantly associated with later stage diagnosis (III/IV). ORs for lack of insurance and lower education were above 1.0, but not consistently statistically significant. These findings substantiate the importance of the affordability and utilization of breast cancer screening.</p>\",\"PeriodicalId\":19247,\"journal\":{\"name\":\"NPJ Breast Cancer\",\"volume\":\"11 1\",\"pages\":\"85\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2025-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12328792/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Breast Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41523-025-00804-0\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Breast Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41523-025-00804-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
美国黑人女性的乳腺癌死亡率高得不成比例,部分原因是晚期诊断。我们通过分析黑人妇女健康研究、卡罗莱纳乳腺癌研究和妇女健康研究圈中4,995名乳腺癌幸存者的数据,研究了健康的社会驱动因素(SDOH)与诊断阶段的关系。SDOH由患者自述,分期由病历确定。我们使用多元逻辑回归来估计III/IV或II期诊断与I期(参考)的比值比(ORs),调整年龄、保险状况和收入。荟萃分析结果显示,乳腺x线筛查的未充分利用(OR = 3.21, 95% CI 1.90-5.43)和收入低于联邦贫困线(OR = 1.91, 95% CI 1.17-3.10)与晚期诊断(III/IV)显著相关。缺乏保险和受教育程度较低的or高于1.0,但在统计学上并不一致。这些发现证实了乳腺癌筛查的可负担性和利用的重要性。
Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women.
U.S. Black women have disproportionately high breast cancer mortality, partly due to later-stage diagnoses. We examined how social drivers of health (SDOH) relate to stage at diagnosis by analyzing data from 4,995 breast cancer survivors in the Black Women's Health Study, Carolina Breast Cancer Study, and Women's Circle of Health Studies. SDOH were self-reported and stage was ascertained from medical records. We used polytomous logistic regression to estimate odds ratios (ORs) for diagnosis at stages III/IV or II versus stage I (referent), adjusting for age, insurance status, and income. Meta-analyzed results indicated that underutilization of screening mammography (OR = 3.21, 95% CI 1.90-5.43) and income below the federal poverty line (OR = 1.91, 95% CI 1.17-3.10) were significantly associated with later stage diagnosis (III/IV). ORs for lack of insurance and lower education were above 1.0, but not consistently statistically significant. These findings substantiate the importance of the affordability and utilization of breast cancer screening.
期刊介绍:
npj Breast Cancer publishes original research articles, reviews, brief correspondence, meeting reports, editorial summaries and hypothesis generating observations which could be unexplained or preliminary findings from experiments, novel ideas, or the framing of new questions that need to be solved. Featured topics of the journal include imaging, immunotherapy, molecular classification of disease, mechanism-based therapies largely targeting signal transduction pathways, carcinogenesis including hereditary susceptibility and molecular epidemiology, survivorship issues including long-term toxicities of treatment and secondary neoplasm occurrence, the biophysics of cancer, mechanisms of metastasis and their perturbation, and studies of the tumor microenvironment.